PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 1, 2024ESMO Open1 citationsOpen Access

63P Treatment-free survival (TFS) in patients (pts) with mNSCLC treated with 1L nivolumab (NIVO) + ipilimumab (IPI) + 2 cycles of chemotherapy (chemo) vs chemo alone (4 cycles) in CheckMate (CM) 9LA

View Full Paper
Ask AI
Bookmark
Share

Authors

MRMartin ReckMRMeredith M. ReganDCD.P. Carbone

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Reck et al. (2024) studied this question.

synapsesocial.com/papers/68e7660bb6db6435876dbbd6https://doi.org/10.1016/j.esmoop.2024.102642
View Full Paper
Ask AI
Bookmark
Share